National Trends in Nonstatin Use and Expenditures Among the US Adult Population From 2002 to 2013: Insights From Medical Expenditure Panel Survey

BACKGROUND: Evidence supporting nonstatin lipid‐lowering therapy in atherosclerotic cardiovascular disease risk reduction is variable. We aim to examine nonstatin utilization and expenditures in the United States between 2002 and 2013. METHODS AND RESULTS: We used the Medical Expenditure Panel Surve...

Descripción completa

Detalles Bibliográficos
Autores principales: Salami, Joseph A., Warraich, Haider J., Valero‐Elizondo, Javier, Spatz, Erica S., Desai, Nihar R., Rana, Jamal S., Virani, Salim S., Blankstein, Ron, Khera, Amit, Blaha, Michael J., Blumenthal, Roger S., Katzen, Barry T., Lloyd‐Jones, Donald, Krumholz, Harlan M., Nasir, Khurram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850149/
https://www.ncbi.nlm.nih.gov/pubmed/29358195
http://dx.doi.org/10.1161/JAHA.117.007132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850149/
https://www.ncbi.nlm.nih.gov/pubmed/29358195
http://dx.doi.org/10.1161/JAHA.117.007132

Ejemplares similares